Erratum to: Safety and Tolerability of Fingolimod in Latin American Patients with Relapsing-Remitting Multiple Sclerosis: The Open-Label FIRST LATAM Study

被引：0

作者：

Laura Ordoñez-Boschetti

Roberto Rey

Ana Cruz

Arijit Sinha

Tracy Reynolds

Nadina Frider

Regina Alvarenga

机构：

[1] Consultorio de Medicina Especializada del Sector Privado,

[2] Instituto Argentino de Investigación Neurológica,undefined

[3] Centro de Investigaciones Médicas Hospital Nacional Alberto Sabogal Sologuren,undefined

[4] Novartis Healthcare Pvt. Ltd.,undefined

[5] Novartis Pharma AG,undefined

[6] Novartis LAtinAmerica and Canada Region,undefined

[7] MS Hospital Da Lagoa,undefined

来源：

Advances in Therapy | 2015年 / 32卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：636 / 636

共 50 条

[31] Use of Fingolimod in the Management of Relapsing-Remitting Multiple Sclerosis: Experience from Latin America [J].

Correale, Jorge ;

Flores, Jose ;

Garcia Bonitto, Juan ;

Carcamo Rodriguez, Claudia ;

Oliveira, Enedina M. L. .

ADVANCES IN THERAPY, 2015, 32 (07) :612-625

[32] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal [J].

Batista, S. ;

Nunes, C. C. ;

Cerqueira, J. J. ;

Martins Silva, Ana ;

Correia de Sa, J. ;

Ferreira, J. ;

Mendonca, M. T. ;

Pinheiro, J. ;

Salgado, V. ;

Correia, A. S. ;

Sequeira, J. ;

Costa, A. ;

Sousa, L. .

NEUROLOGICAL SCIENCES, 2021, 42 (05) :1995-2003

[33] REALMS study: real-world effectiveness and safety of fingolimod in patients with relapsing-remitting multiple sclerosis in Portugal [J].

S. Batista ;

C. C. Nunes ;

J. J. Cerqueira ;

Ana Martins Silva ;

J. Correia de Sá ;

J. Ferreira ;

M. T. Mendonça ;

J. Pinheiro ;

V. Salgado ;

A. S. Correia ;

J. Sequeira ;

A. Costa ;

L. Sousa .

Neurological Sciences, 2021, 42 :1995-2003

[34] An open-label, prospective study of oral fumaric acid therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) [J].

Schimrigk, SK ;

Brune, N ;

Hellwig, K ;

Rieks, M ;

Hoffmann, V ;

Pohlau, D ;

Przuntek, H .

NEUROLOGY, 2005, 64 (06) :A392-A393

[35] A prospective, open-label, phase II study of oral fumarate therapy for the treatment of relapsing-remitting multiple sclerosis [J].

Schimrigk, S ;

Brune, N ;

Hellwig, K ;

Rieks, M ;

Hoffmann, V ;

Pöhlau, D ;

Przuntek, H .

MULTIPLE SCLEROSIS, 2004, 10 (7032) :S258-S259

[36] Safety and efficacy with alemtuzumab over 13?years in relapsing-remitting multiple sclerosis: final results from the open-label TOPAZ study [J].

Coles, Alasdair J. ;

Achiron, Anat ;

Traboulsee, Anthony ;

Singer, Barry A. ;

Pozzilli, Carlo ;

Oreja-Guevara, Celia ;

Giovannoni, Gavin ;

Comi, Giancarlo ;

Freedman, Mark S. ;

Ziemssen, Tjalf ;

Shiota, Debora ;

Rawlings, Andreea M. ;

Wong, Alana T. ;

Chirieac, Magdalena ;

Montalban, Xavier .

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2023, 16

[37] Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study [J].

Gold, Ralf ;

Radue, Ernst-Wilhelm ;

Giovannoni, Gavin ;

Selmaj, Krzysztof ;

Havrdova, Eva ;

Stefoski, Dusan ;

Sprenger, Till ;

Montalban, Xavier ;

Cohan, Stanley ;

Umans, Kimberly ;

Greenberg, Steven J. ;

Ozen, Gulden ;

Elkins, Jacob .

BMC NEUROLOGY, 2016, 16

[38] Safety and tolerability of BG-12 in patients with relapsing-remitting multiple sclerosis: results from the phase 3 CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study [J].

Havrdova, E. ;

Phillips, J. T. ;

Fox, R. J. ;

Miller, D. ;

Kita, M. ;

Hutchinson, M. ;

Raghupathi, K. ;

Yuan, H. ;

Novas, M. ;

Sweetser, M. T. ;

Viglietta, V. ;

Dawson, K. T. .

JOURNAL OF NEUROLOGY, 2012, 259 :S105-S105

[39] Safety and efficacy of daclizumab in relapsing-remitting multiple sclerosis: 3-year results from the SELECTED open-label extension study [J].

Ralf Gold ;

Ernst-Wilhelm Radue ;

Gavin Giovannoni ;

Krzysztof Selmaj ;

Eva Havrdova ;

Dusan Stefoski ;

Till Sprenger ;

Xavier Montalban ;

Stanley Cohan ;

Kimberly Umans ;

Steven J. Greenberg ;

Gulden Ozen ;

Jacob Elkins .

BMC Neurology, 16

[40] Effectiveness of fingolimod in Spanish patients with relapsing-remitting multiple sclerosis in the clinical practice [J].

Meca-Lallana, V. ;

Martinez Yelamos, S. ;

Mallada, J. ;

Meca-Lallana, J. ;

Martinez, M. ;

Marzo, E. ;

Duran, C. ;

Ayuso, T. ;

Barrero, F. ;

Romero, R. ;

Guillen, R. ;

Ricart, J. ;

Garcia, E. .

MULTIPLE SCLEROSIS JOURNAL, 2017, 23 :855-855

← 1 2 3 4 5 →